Not to be a knitpicker, but RNA is not the complement to DNA, it is the transcribed mirror to DNA and also contains one base (Uracil) that is different than DNA. RNAi complexes with the target mRNA in the cell and degrades it (through the RiSC), thusly inhibiting protein production (translation) of that mRNA.
Other than that, i agree with you 100%, great DD!
hey jeg, havent read the patent application above yet.
i plan to do so over the weekend, but again, i dont get excited over applications as they are a dime a dozen and only serve to be prior art if they dont issue. B2 is where its at.
an application may take years to grant, usually 4ish.
to play devils advocate, here is a scenario for you, pure speculation as you asked for a scenario and this one came to mind.
Science is proven and patent issues in 2021
MANF is off patent for AMBS
Bascom can partner with whoever they want
AMBS plays hardball
Bascom says eff off, we will go with company X
AMBS has nothing
i realize that this is an unlikely scenario, but weird things happen when money is on the line and people play hardball/arent good at negotiations with partners
good luck jegfu
you already said it, if a patent is actually issued, they have first right of refusal to license it
LICENSE someone elses patent, as I said above, i hope they can work something out to be in the mix, but that is certainly no guarantee. did you not understand that I hope they figure out something to be in the mix? how can I be more clear than that?
1) patent must be granted
2) AMBS has to find terms to license under
3) AMBS has to figure out how to make a product
4) AMBS has to sell a product
5) AMBS will have to give royalties to Bascom
thats a lot of "IFS"
whats your angle on this?
what orphan status? i havent seen any approvals. the patent expiry is 2021, 6.5 years away. that is a concrete, irrefutable fact (that you couldnt figure out by the way). you can dream of orphan status all you want, AMBS doesnt have it and until then it is a non factor in generating income. try again MKF, your arguments get weaker and weaker by the day and are based more and more on hopes, dreams and speculation
come on now M, this is a "world class BOD" "if you cant handle timeline shifts dont be in a penny biotech" "you dont know what they are planning or doing"
Dont forget, a contrary opinion is considered bashing, have blind faith in the BoD and you will reach salvation
nice find jegfsu. Too bad that AMBS will not be the owner of the patent and the associated royalties, but perhaps they can work something out to be in the mix. ill get excited about it when it becomes a B2 rather than an A1 patent.
Im sorry you couldnt answer my question MKF. perhaps you arent the expert you propose to be?
nice job dotcom. at least someone else here knows how to look up patents. you are close on expiration date, it is March 2021. I still give you marks for the work.
how many of these patents are owned by amarantus?
so you and idiotpatrol dont know? As I thought. Maybe you should do some more DD. I did part of your homework for you, I cant hold your hand on this.
Curious to see your patent reading skills
Im not going to do your DD for you, but you should know this since you are so high on MANF.
What I will do, to make your life easier, is to give you the patent number
I look forward to your answer
how droll MKF. i am sooo happy you are here to enlighten us with the mistakes management has made in the past (poor hires, poor execution).
It doesnt matter, according to skas above, some entity is looking for 70000 entrants. If they are looking for that many (which is 1000 times more than AMBS) they plan to find that many people for testing between the control and the test group. Why cant AMBS find 72 in a reasonable amount of time? They are taking a blood sample for Gods sake! Its not like the person has to be on the table for 6 hours for the test, its a blood draw like at red cross!
And as for your comment below about not knowing what the screening method is, what do you think the screening method should be? Remember, this presumptive test is not going to get to choose who it is being used on, there will be Alz and non Alz people of both genders of varying ages, ethnicities and health states taking the test presumably
That was all pump and dump through money runners and other penny stock promotion companies. I am not sure that those buyers are legitimate to the long term appreciative price of AMBS